B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PSMB4

MOLECULAR TARGET

proteasome 20S subunit beta 4

UniProt: P28070NCBI Gene: 56922 compounds

PSMB4 (proteasome 20S subunit beta 4) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PSMB4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Bortezomib2.7114
2Reserpine1.614

About PSMB4 as a Drug Target

PSMB4 (proteasome 20S subunit beta 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented PSMB4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PSMB4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.